Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Precigen (PGEN)
NASDAQ:PGEN
Precigen (PGEN) Stock Price & Analysis
845 Followers
PGEN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.84 - $1.93
Previous Close$1.59
Volume872.83K
Average Volume (3M)859.62K
Market Cap
$401.35M
Enterprise Value$353.48M
Total Cash (Recent Filing)$99.29M
Total Debt (Recent Filing)$51.42M
Price to Earnings (P/E)―
Beta1.62
Next Earnings
Aug 05, 2024EPS Estimate
-$0.1Last Dividend Ex-Date
Jan 19, 2017Dividend YieldN/A
Share Statistics
EPS (TTM)-0.39
Shares Outstanding252,419,690
10 Day Avg. Volume687,561
30 Day Avg. Volume859,617
Standard Deviation0.28
R-Squared0.13
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)8.66
Price to Sales (P/S)-15.71
Price to Cash Flow (P/CF)-6.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue13.14
Enterprise Value/Gross Profit17.18
Enterprise Value/Ebitda-5.74
Forecast
1Y Price Target
$10.00Price Target Upside528.93% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Precigen News
PremiumCompany Announcements
Precigen’s Annual Meeting Decisions and Director Departure
Bulls Say, Bears Say
Bulls Say
Clinical EfficacyPRGN-2012 pivotal results in RRP demonstrate best-case scenario, maintaining >50% complete response rate.
Market PotentialPRGN-2012 is likely to become the standard-of-care in RRP, indicating a strong potential for market uptake.
Regulatory MilestonePrecigen is on track to complete the rolling BLA submission for PRGN-2012, reflecting progress in the regulatory process.
Bears Say
Clinical Trial OutcomesThe complete response rate for PRGN-2012 could significantly impact Precigen's stock if it falls below expectations or if safety issues emerge.
EarningsPrecigen's reported total revenue falls short of the consensus estimated revenue.
Financial PerformancePrecigen's reported net loss per share is greater than the consensus estimates, indicating potential financial weakness.
---
Ownership Overview
48.90% Insiders
14.39% Mutual Funds
6.07% Other Institutional Investors
30.65% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PGEN FAQ
What was Precigen’s price range in the past 12 months?
Precigen lowest stock price was $0.83 and its highest was $1.93 in the past 12 months.
What is Precigen’s market cap?
Currently, no data Available
When is Precigen’s upcoming earnings report date?
Precigen’s upcoming earnings report date is Aug 05, 2024 which is in 14 days.
How were Precigen’s earnings last quarter?
Precigen released its earnings results on May 14, 2024. The company reported -$0.1 earnings per share for the quarter, missing the consensus estimate of -$0.088 by -$0.012.
Is Precigen overvalued?
According to Wall Street analysts Precigen’s price is currently Undervalued.
Does Precigen pay dividends?
Precigen pays a Notavailable dividend of $0.24 which represents an annual dividend yield of N/A. See more information on Precigen dividends here
What is Precigen’s EPS estimate?
Precigen’s EPS estimate is -$0.1.
How many shares outstanding does Precigen have?
Precigen has 252,419,700 shares outstanding.
What happened to Precigen’s price movement after its last earnings report?
Precigen reported an EPS of -$0.1 in its last earnings report, missing expectations of -$0.088. Following the earnings report the stock price went up 5.109%.
Which hedge fund is a major shareholder of Precigen?
Among the largest hedge funds holding Precigen’s share is Third Security, Llc. It holds Precigen’s shares valued at 121M.
---
Precigen Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$10.00 (528.93% Upside)
$10.00 (528.93% Upside)
Blogger Sentiment
Bullish
PGEN Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 16.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.7%
Last 30 Days ▼ 4.5%
Last 30 Days ▼ 4.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
12.76%
12-Months-Change
Fundamentals
Return on Equity
-68.94%
Trailing 12-Months
Asset Growth
-44.17%
Trailing 12-Months
Company Description
Precigen
Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It focuses on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals. The product pipeline includes Isobutanol, Isobutyraldehyde, Farnesene, and Isoprene. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.
---
PGEN Earnings Call
Q4 2024
0:00 / 0:00
---
PGEN Stock 12 Month Forecast
Average Price Target
$10.00
▲(528.93% Upside)
Technical Analysis
Best Analysts Covering PGEN
1 Year
1 Year Success Rate
7/15 ratings generated profit
1 Year Average Return
-15.73%
reiterated a buy rating 2 months ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 46.67% of your transactions generating a profit, with an average return of -15.73% per trade.
---